The Spring session of CMEpalooza featured two full days of live programming designed for the continuing medical education community. This year, PlatformQ Health (PQH) sent two delegates to the session titled Including Patients and Patient Advocacy Groups in Educational Planning & Delivery: How to Make It a “Win-Win”. Senior VP of Education, Kathryn Pucci, acted […]
February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA) […]
Schizophrenia is a mental health disorder that is chronic and disabling and affects the way a person thinks, feels, and behaves. Typically, symptoms start between the ages of 16 and 30; rarely it is observed in children as well. Symptoms of this disease are categorized into 3 types – positive, negative, and cognitive: Positive symptoms: These […]
PlatformQ Health Education, in joint providership with the American Academy of Family Physicians (AAFP), announces the first of two online educational programs on shared decision making in major depressive disorder (MDD) treatment. Major depressive disorder (MDD) has substantial negative effects on patients’ functional abilities and quality of life. This tethered, or mutual, education will focus […]
Healthcare professionals and policymakers are struggling to come to terms with the epidemic of opioid abuse and overdose in the United States – perhaps nowhere more than here in Massachusetts, where the presence of premier medical institutions has not been able to stem the state’s record high rates of opioid-overdose deaths (which are among the […]
Pseudobulbaa affect (PBA) typically presents as episodes of uncontrollable laughing or crying that is out of context to the current social situation. The patient’s emotional expression is incongruent to their emotional state. Usually, PBA is seen in the setting of other neurologic diseases such as ALS, Parkinson’s disease, Alzeihmer’s dementia, stroke, progressive MS, brain tumors, […]
Did you know there is a relationship between Alzheimer’s & depression? In the US, Alzheimer’s Disease (AD) is the sixth leading cause of death with greater than 5 million people currently living with the disease. Since the year 2000, deaths from cardiovascular disease have decreased by 14% while there have been an 89% increase in deaths caused […]
According to statistics compiled from the CDC, more than 165,000 people in the US died as a result of overdoses due to prescription medications from 1999 to 2014. The rate continues climbing with over 14,000 deaths in 2014 alone. While death is the most dangerous end-point, that is just the tip of the iceberg. It […]
Motivational interviewing is a form of counseling developed by William R. Miller, PhD and Professor Steven Rollinick in 1983. First devised to help in the treatment of alcoholics, motivational interviewing can serve as a framework for evoking any motivation to change and has been used for many conditions including substance abuse, smoking, obesity and diabetes. […]